GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Diplomat Pharmacy Inc (NYSE:DPLO) » Definitions » Days Payable

Diplomat Pharmacy (Diplomat Pharmacy) Days Payable : 25.62 (As of Sep. 2019)


View and export this data going back to 2014. Start your Free Trial

What is Diplomat Pharmacy Days Payable?

Diplomat Pharmacy's average Accounts Payable for the three months ended in Sep. 2019 was $347 Mil. Diplomat Pharmacy's Cost of Goods Sold for the three months ended in Sep. 2019 was $1,238 Mil. Hence, Diplomat Pharmacy's Days Payable for the three months ended in Sep. 2019 was 25.62.

The historical rank and industry rank for Diplomat Pharmacy's Days Payable or its related term are showing as below:

DPLO's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 87.13
* Ranked among companies with meaningful Days Payable only.

Diplomat Pharmacy's Days Payable increased from Sep. 2018 (24.92) to Sep. 2019 (25.62). It may suggest that Diplomat Pharmacy delayed paying its suppliers.


Diplomat Pharmacy Days Payable Historical Data

The historical data trend for Diplomat Pharmacy's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diplomat Pharmacy Days Payable Chart

Diplomat Pharmacy Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Days Payable
Get a 7-Day Free Trial 30.33 29.35 27.18 30.57 24.71

Diplomat Pharmacy Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.92 22.45 22.94 22.92 25.62

Competitive Comparison of Diplomat Pharmacy's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Diplomat Pharmacy's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diplomat Pharmacy's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Diplomat Pharmacy's Days Payable distribution charts can be found below:

* The bar in red indicates where Diplomat Pharmacy's Days Payable falls into.



Diplomat Pharmacy Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Diplomat Pharmacy's Days Payable for the fiscal year that ended in Dec. 2018 is calculated as

Days Payable (A: Dec. 2018 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2017 ) + Accounts Payable (A: Dec. 2018 )) / count ) / Cost of Goods Sold (A: Dec. 2018 )*Days in Period
=( (384.719 + 308.084) / 2 ) / 5116.515*365
=346.4015 / 5116.515*365
=24.71

Diplomat Pharmacy's Days Payable for the quarter that ended in Sep. 2019 is calculated as:

Days Payable (Q: Sep. 2019 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2019 ) + Accounts Payable (Q: Sep. 2019 )) / count ) / Cost of Goods Sold (Q: Sep. 2019 )*Days in Period
=( (326.544 + 368.41) / 2 ) / 1237.812*365 / 4
=347.477 / 1237.812*365 / 4
=25.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diplomat Pharmacy Days Payable Related Terms

Thank you for viewing the detailed overview of Diplomat Pharmacy's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Diplomat Pharmacy (Diplomat Pharmacy) Business Description

Traded in Other Exchanges
N/A
Address
4100 South Saginaw Street, Flint, MI, USA, 48507
Diplomat Pharmacy Inc. is active in the U.S. healthcare sector. It provides specialty pharmacy and infusion services, including pharmacy solutions for chronic diseases. The company has two main segments: specialty pharmacy and pharmacy benefit management. Its specialty pharmacy segment offers solutions to dispense, deliver, and dose prescription drugs. The pharmacy benefit management segment offers services to help control pharmacy benefit dollars and maximize quality of care. It derives most of its revenue through prescription drug sales in the United States.
Executives
Brian T Griffin director, officer: Chairman and CEO
David C Dreyer director C/O SICOR INC, 19 HUGHES, IRVINE CA 92618-1902
Shawn Tomasello director C/O PHARMACYCLICS, INC, 995 EAST ARQUES AVENUE, SUNNYVALE CA 94085
Regina M. Benjamin director 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Benjamin Wolin director C/O EVERYDAY HEALTH, INC., 345 HUDSON STREET, 16TH FLOOR, NEW YORK NY 10014
Jeffrey G Park director C/O DIPLOMAT PHARMACY, INC., 4100 S. SAGINAW ST., FLINT MI 48507
Sean Whelan director, officer: Chief Financial Officer C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108
Jeffrey M Rowe director, officer: EVP of Operations C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018

Diplomat Pharmacy (Diplomat Pharmacy) Headlines

From GuruFocus

Diplomat Appoints Dave Loschinskey as Chief Operating Officer

By PRNewswire PRNewswire 05-07-2019